March 2010
·
1,329 Reads
·
6 Citations
International Journal of PharmTech Research
Helicobacter pylori (H. pylori) infect more than half of the world population, making it one of the most prevalent infections. H. pylori is now accepted as the most common cause of histologic gastritis and is responsible for the majority of cases of peptic ulcer disease and gastric cancer. Approximately 1 in 6 (17%) persons with H. pylori infection will develop peptic ulcer disease, and each year 1% to 2% of these will experience a major or life-threatening complication, and this basically occurs due to short gastric residence time of antimicrobial agents, keeping that in mind mucoadhesive microspheres were prepared to increase gastric residence time using solvent evaporation method. The (mucoadhesive) sustained release of amoxicillin trihydrate is desired because of its short biological half-life. Predominantly to treat H. pylori infections, the mucoadhesive is desired to be confined to the upper gastrointestinal tract. Amoxicillin trihydrate mucoadhesive microspheres were prepared using Eudragit RS100 as matrix and HPMC K4M as mucoadhesive polymer for the potential use of treating gastric and duodenal ulcers, which were associated with H.pylori. The morphological characteristics of the mucoadhesive microspheres were studied under scanning electron microscope. The percentage yield of microspheres of all formulation was in the range of 78.90% to 90.95%. The drug content determination showed that even if the polymer composition was changed the solvent evaporation process was highly efficient to give microspheres having maximum drug loading. In termination, the prolonged gastrointestinal residence time and enhanced amoxicillin trihydrate stability resulting from the mucoadhesive microspheres of amoxicillin trihydrate might make contribution to H. pylori clearance.